These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 18038763

  • 1. The effect of Tc-99m-labeled MDM2 antisense oligonucleotide on gene expression in human breast cancer MCF-7 cells.
    Zhao C, Fu P, Sheng Y, Li Z.
    J Exp Ther Oncol; 2007; 6(4):297-303. PubMed ID: 18038763
    [Abstract] [Full Text] [Related]

  • 2. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
    Fu P, Shen B, Zhao C, Tian G.
    J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M, Wang RF, Zhang CL, Yan P, Yu MM, Di LJ, Liu HJ, Guo FQ.
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [Abstract] [Full Text] [Related]

  • 4. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
    Zhang YR, Zhang YX, Cao W, Lan XL.
    J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
    [Abstract] [Full Text] [Related]

  • 5. [Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs].
    Fan C, Hnatowich DJ.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):712-5. PubMed ID: 18693462
    [Abstract] [Full Text] [Related]

  • 6. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.
    Wang H, Nan L, Yu D, Agrawal S, Zhang R.
    Clin Cancer Res; 2001 Nov; 7(11):3613-24. PubMed ID: 11705884
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radiosensitization by antisense anti-MDM2 mixed-backbone oligonucleotide in in vitro and in vivo human cancer models.
    Zhang Z, Wang H, Prasad G, Li M, Yu D, Bonner JA, Agrawal S, Zhang R.
    Clin Cancer Res; 2004 Feb 15; 10(4):1263-73. PubMed ID: 14977824
    [Abstract] [Full Text] [Related]

  • 9. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H, Yu D, Agrawal S, Zhang R.
    Prostate; 2003 Feb 15; 54(3):194-205. PubMed ID: 12518324
    [Abstract] [Full Text] [Related]

  • 10. Anti-sense oligonucleotide labeled with technetium-99m using hydrazinonictinamide derivative and N-hydroxysuccinimidyl S-acetylmercaptoacetyltriglycline: a comparison of radiochemical behaviors and biological properties.
    Li YC, Tan TZ, Zheng JG, Zhang C.
    World J Gastroenterol; 2008 Apr 14; 14(14):2235-40. PubMed ID: 18407601
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Use of 99mTc-survivin antisense oligonucleotide in diagnosis of hepatocellular carcinoma: an experiment with mice].
    Gao ZR, Zhang YX, Zhang KJ.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 31; 85(33):2327-30. PubMed ID: 16321225
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [In vivo imaging of breast tumors by a 99mTc radiolabeled probe targeting microRNA-155 in mice models].
    Kang L, Huo Y, Wang RF, Zhang CL, Yan P, Xu XJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr 18; 50(2):326-330. PubMed ID: 29643534
    [Abstract] [Full Text] [Related]

  • 16. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
    Li Y, Tan T, Zheng J, Zhang C.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug 18; 25(4):889-93, 902. PubMed ID: 18788302
    [Abstract] [Full Text] [Related]

  • 17. MDM2 molecular imaging for the prediction of chemotherapeutic sensitivity in human breast cancer xenograft.
    Fu P, Sun L, Cao X, Li L, Zhao C.
    Mol Imaging; 2014 Aug 18; 13():. PubMed ID: 25022573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms.
    Wang H, Wang S, Nan L, Yu D, Agrawal S, Zhang R.
    Int J Oncol; 2002 Apr 18; 20(4):745-52. PubMed ID: 11894120
    [Abstract] [Full Text] [Related]

  • 20. P53 regulation of leukemia cells with the blockage of MDM2 by antisense oligonucleotides.
    Fang M, Ji X, Tang Y, Liu W.
    J Huazhong Univ Sci Technolog Med Sci; 2006 Apr 18; 26(4):414-6. PubMed ID: 17120736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.